New Astronomer CEO says Coldplay scandal made company a 'household name'
Co-founder Pete DeJoy assumed the role of interim CEO after a viral video reportedly showed CEO Andy Byron and the company's chief people officer embracing on the Jumbotron during a July 18 show, according to the New York Times.
Following the scandal, the company announced via posts to X and LinkedIn that Byron had "tendered his resignation."
In a new LinkedIn post titled 'Moving Forward at Astronomer,' DeJoy broke his silence on the controversy with a more positive take on the situation.
New Astronomer interim CEO speaks on scandal
'The events of the past few days have received a level of media attention that few companies — let alone startups in our small corner of the data and AI world — ever encounter,' DeJoy wrote in the Monday, July 21 post.
'The spotlight has been unusual and surreal for our team and, while I would never have wished for it to happen like this, Astronomer is now a household name," he said.
'From starting a software company in Cincinnati, Ohio, to keeping the lights on through the collapse of the bank that held all our cash, to scaling from 30 to 300 people during a global pandemic that demanded we do it all without ever being in the same room,' DeJoy wrote. 'And yet, we're still here.'
Has Andy Byron spoken up about the scandal?
Byron has yet to publicly address the controversy or his leave of absence at Astronomer. The company has dismissed a recent fabricated statement impersonating Byron.
The video of the July 16 incident at Gillette Stadium has received more than 124 million views on TikTok alone.
The viral moment shows a man and a woman embracing each other before quickly letting go and ducking out of view when a "Kiss Cam" put them in the spotlight at the Foxborough, Massachusetts stadium.
'Uh oh, what? Either they're having an affair or they're just very shy,' Coldplay lead singer Chris Martin quipped at the time.
Astronomer didn't specify exactly why Byron resigned but on LinkedIn wrote the company "is committed to the values and culture that have guided us since our founding. Our leaders are expected to set the standard in both conduct and accountability."
The company did not respond to USA TODAY's requests for comment.
This article originally appeared on USA TODAY: New Astronomer CEO calls Coldplay scandal 'surreal' in first statement
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
(Reuters) -Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies. Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients. On an adjusted basis, Thermo Fisher reported a profit of $5.36 per share for the quarter ended June 28, beating analysts' estimate of $5.22 per share, as per data compiled by LSEG. The company said its business strategy called "practical process improvement" is helping adjust its supply chains in the tariff environment and to actively manage its cost base. Last week, the company said it will buy French drugmaker Sanofi's New Jersey manufacturing site, "to meet growing demand from pharma and biotech customers." The Waltham Massachusetts-based company's quarterly revenue rose 3% to $10.85 billion, compared to analyst estimates of $10.68 billion. Sales at its laboratory products segment, which makes up more than half of Thermo Fisher's total sales came in at $6 billion, above estimates of $5.79 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Highly shorted Krispy Kreme, GoPro jump as meme stock rally continues
(Reuters) -Shares of some highly-shorted companies, including Krispy Kreme and GoPro, jumped in premarket trading on Wednesday, aided by their names trending on social media forums a day after retail traders piled into department store company Kohl's. Doughnut chain Krispy Kreme jumped 16.1%, building on a near 27% surge on Tuesday. About 14% of Krispy Kreme's outstanding shares available for trading are shorted, according to data compiled by LSEG. Camera maker GoPro also surged about 47% to $2.01. Short interest on the stock was last at 7.7%. Another highly shorted stock - with short interest at 36.7% - was plant-based meat company Beyond Meat, whose shares jumped 10.4% on Wednesday. The growing interest in heavily shorted stocks comes after Kohl's surged 37.6% higher in volatile trading on Tuesday on the back of high retail interest. Mom-and-pop traders bought $9.64 million of its shares that day, the most by this category of investors in about three years, according to data from Vanda Research. Kohl's was flat in premarket trading on Wednesday but is the third most trending ticker on Stocktwits, a retail investor-focused social media platform. Among other highly shorted names, online gifts retailer rose 8.1%. Opendoor Technologies, which has rocketed 440% so far this month, was down 2.6% on Wednesday.
Yahoo
17 minutes ago
- Yahoo
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
-- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts. The company reported adjusted EPS of $5.36, beating the analyst estimate of $5.23. Revenue rose 3% from a year earlier to $10.85 billion, above the $10.68 billion consensus. Shares in the medical equipment maker were up 2.3% in premarket trading Wednesday as of 06:06 ET. 'Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment," said Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific. Adjusted operating income reached $2.38 billion, slightly up from $2.35 billion in the same period last year. Adjusted operating margin slipped to 21.9% from 22.3% a year ago. Related articles Thermo Fisher shares climb as Q2 top and bottom line exceed estimates These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia If Powell goes, does Fed trust go with him?
